Prollenium Medical Technologies
10670 Yonge Street
Richmond Hill
Ontario
L4C 3C9
Canada
Tel: 905-508-1469
Fax: 905-508-6716
Website: http://www.prollenium.com/
Email: info@prollenium.com
11 articles about Prollenium Medical Technologies
-
Prollenium Medical Technologies Announces The Appointment Of Its New President Of US Operations, Sean L. Wilson
9/5/2017
-
Prollenium Medical Technologies Announces U.S. FDA Approval For Its Cross-Linked Hyaluronic Acid Dermal Filler
8/18/2017
-
Prollenium Medical Technologies Acquires Rights To Distribute Selphyl
2/13/2017
-
Prollenium Medical Technologies Release: Lyracaine Topical Anesthetic Now Approved For Sale In Canada
10/1/2014
-
Prollenium Medical Technologies Acquires Rights To Distribute Alyria Skincare
9/25/2014
-
Prollenium Medical Technologies On PROFIT 500 List 2014
6/17/2014
-
Prollenium Medical Technologies Reacquires Ovita® HV Brand for Global Distribution
6/24/2013
-
Prollenium Medical Technologies Launch First and Only Dermal Filler Manufacturing Facility in Canada
6/12/2013
-
Prollenium Medical Technologies No. 292 on PROFIT 500 List 2013
6/10/2013
-
Prollenium Medical Technologies Bucks Market Trend; Increases Expenditures on Product Development and Global Distribution Activities
3/19/2009
-
Prollenium Medical Technologies Announces Partnership Agreement with Ajanta Pharma to Market Revanesse(R) in India
9/17/2007